Cytosorbents Corp
CTSO
53 hedge funds and large institutions have $22.6M invested in Cytosorbents Corp in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 9 closing their positions.
9% more capital invested
Capital invested by funds: $20.7M → $22.6M (+$1.85M)
6% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 16
0.51% less ownership
Funds ownership: 34.09% → 33.58% (-0.51%)
12% less funds holding
Funds holding: 60 → 53 (-7)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$289K |
| 2 |
AC
Avenir Corporation
Alexandria,
Virginia
|
+$196K |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$123K |
| 4 |
Neuberger Berman Group
New York
|
+$73.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
CM Management
Gulf Breeze,
Florida
|
-$297K |
| 2 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
-$184K |
| 3 |
E
Ergoteles
New York
|
-$119K |
| 4 |
Renaissance Technologies
New York
|
-$118K |
| 5 |
Millennium Management
New York
|
-$59K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HGWM
51
Harvest Group Wealth Management
Waltham,
Massachusetts
| $57 | – | – | – |
|
52
Group One Trading
Chicago,
Illinois
| $28 | -$2.43K | -1,636 | -99% |
|
53
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$43K | -31,434 | Closed |
|
|
WPA
54
Winning Points Advisors
Boca Raton,
Florida
| – | -$33K | -22,900 | Closed |
|
55
Two Sigma Advisers
New York
| – | -$23K | -16,600 | Closed |
|
|
LP
56
LMR Partners
London,
United Kingdom
| – | -$20K | -14,709 | Closed |
|
57
Goldman Sachs
New York
| – | -$16K | -11,618 | Closed |
|
58
Commonwealth Equity Services
Waltham,
Massachusetts
| – | -$13K | -10,129 | Closed |
|
|
TRCT
59
Tower Research Capital (TRC)
New York
| – | -$1K | -958 | Closed |
|
|
BBHC
60
Brown Brothers Harriman & Co
New York
| – | -$1K | -601 | Closed |
|
|
GKIM
61
GW&K Investment Management
Boston,
Massachusetts
| – | +$45 | +30 | New |
|
CTSO Hedge Fund Activity: Q4 2022 in Review
53 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q4 2022, worth a combined $22.6M — up 8.9% from $20.7M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of CTSO and 4 opened new positions — a net loss of 5 holders — while 16 trimmed existing stakes and 17 added.
The largest buyer was Skylands Capital, adding an estimated $289K. The largest seller was CM Management, cutting an estimated $297K.
- 53 institutional investors held Cytosorbents Corp (CTSO) as of Q4 2022, down from 60 in Q3 2022.
- Funds reported $22.6M of Cytosorbents Corp stock for Q4 2022, up 8.9% quarter-over-quarter.
- 4 funds opened new Cytosorbents Corp positions in Q4 2022 and 9 closed out, a net change of -5 holders.
- The largest Cytosorbents Corp buyer in Q4 2022 was Skylands Capital, an estimated $289K added.
- The largest Cytosorbents Corp seller in Q4 2022 was CM Management, an estimated $297K sold.
Based on aggregated 13F filings for Q4 2022.